Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 mai 2023 21h13 HE | Source: Love Pharma

JOLT Health Inc. Announces Issuance of Common Shares in Satisfaction of Interest Payments to Promissory Note Holders and Interest Payment to Convertible Debenture Holder

VANCOUVER, BC, CANADA, May 25, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (formerly Love Pharma Inc.) (“Jolt” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) is pleased to announce that pursuant to a...
16 mai 2023 18h51 HE | Source: Love Pharma

LOVE PHARMA INC. ANNOUNCES CHANGE OF NAME TO “JOLT HEALTH INC.” AND INCREASED FOCUS ON BIOTECHNOLOGY

VANCOUVER, BC, CANADA, May 16, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has changed its name to “Jolt Health...
05 avr. 2023 16h30 HE | Source: Love Pharma

LOVE PHARMA TO EVALUATE MINING OPPORTUNITIES

VANCOUVER, BC, CANADA, April 05, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is currently evaluating mining opportunities in the battery component...
03 avr. 2023 16h30 HE | Source: Love Pharma

LOVE PHARM INC. ANNOUNCES GRANT OF STOCK OPTIONS

VANCOUVER, BC, CANADA, April 03, 2023 (GLOBE NEWSWIRE) -- LOVE Pharma Inc. (“LOVE” and or “the Company”) (CSE:LUV) (FSE: G1Q0) is pleased to announce that it has issued a total of 5,035,000 options...